DWTX logo

Dogwood Therapeutics, Inc.

DWTX
Healthcare|Biotechnology|US
$1.28
+0.24 (+23.08%)
DCF Value
$0.69
Cash / Share
$144984.79
Next Earnings Report
Mar 17, 2027
EPS est. -$0.16 · Revenue est. $100.0K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Oct 30, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
P2Chemotherapy Induced Neuropathic Pain
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

SEC Filings (18)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Oct 30, 2026S-3Shelf registrationDocumentIndex
Oct 27, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Oct 21, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 7, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 20, 2025DEF 14AProxy / shareholder voteDocumentIndex
Oct 16, 2025S-3/AShelf registrationDocumentIndex
Oct 9, 2025DEFA14AProxy / shareholder voteDocumentIndex
Oct 9, 20258-KMaterial eventDocumentIndex
Oct 8, 2025PRE 14AProxy / shareholder voteDocumentIndex
Oct 1, 2025S-3Shelf registrationDocumentIndex
Sep 29, 2025DEFA14AProxy / shareholder voteDocumentIndex
Sep 29, 20258-KMaterial eventDocumentIndex
Aug 13, 202510-QQuarterly reportDocumentIndex
Aug 13, 20258-KMaterial eventDocumentIndex
Jul 2, 20258-KMaterial eventDocumentIndex